Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPrevention and treatment of lymphorrhoea following surgery for gastric cancer
Australian and New Zealand Journal of Surgery, 10/12/09
Lin SZ et al. – Ligating rather than cauterizing the disrupted lymph vessels can be done to minimize the incidence of lymphorrhoea. The combination of Octreotide and TPN appears to be an effective therapeutic modality for lymphorrhoea.
Related Articles
Palliation of advanced gastrointestinal malignancies using minimally invasive strategies
Progress in Palliative Care, 10/02/09
Relevance Score: 66%
Image-enhanced endoscopy in practice
Canadian Journal of Gastroenterology, 11/06/09
Relevance Score: 65%
Surgery for Gastrointestinal Stromal Tumors of the Duodenum
Annals of Surgical Oncology, 10/23/09
Relevance Score: 65%
Paraneoplastic dermatological manifestation of gastrointestinal malignancies
World Journal of Gastroenterology, 10/01/09
Relevance Score: 65%
Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population
Digestive Diseases and Sciences, 10/21/09
Relevance Score: 64%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
Alimentary Pharmacology and Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor